Moderna on Tuesday said it has begun its first human trial of an experimental vaccine to protect against Bundibugyo ebolavirus, a strain of Ebola that has killed more than 1,650 people so far and currently has no approved vaccine.
Trending
- Brand New Day Hits $1 Billion at Global Box Office
- Wildfire prevention requires 'nature-based solutions': Land 'treating us' the way we treat the land
- Hannah Einbinder Talks New Slasher Film, Scream Therapy, More
- Moderna begins first human trial of Bundibugyo Ebola vaccine
- Hezbollah rejects fresh round of talks between Lebanon and Israel
- 'Full solidarity' with Spain after Ceuta crisis: Brunner
- Pentagon boosts Patriot, THAAD interceptor output amid stockpile strain | Military News
- Study shows why younger generations may be more cancer-prone
